Definitive Contract 75N95019C00019
Award Date
5/1/19
Potential Completion Date
1/31/20
Potential Value
$235K
Federal Agency
National Institute on Drug Abuse
Awardee
Lacell LLC
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
New Orleans, LA 70112, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) to Lynntech Inc., a small business. The contract is for the development of non-polydimethylsiloxane (PDMS) biocompatible alternatives for organs-on-chips, a topic under NCATS SBIR 2019 solicitation. The contract has a firm fixed-price of $225,000.00 and a completion date of January 31, 2020. Lynntech Inc. is a small business that...
The Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse awarded a $105,000 firm fixed price purchase order to New York Stem Cell Foundation Inc. as the prime contractor. The contract is to support the agency's research efforts and will be performed in New York, New York over a one year period from September 2023 through September 2024. No major subcontractors or set aside designations were indicated. The National Institute on Drug Abuse...
S-3 Research LLC has been awarded a $1.5 million firm fixed price contract by the National Institutes of Health's National Institute on Drug Abuse to further develop and commercialize a minimum viable product originally created under Phase I of the Small Business Innovation Research program. Over the next two years, the company will focus on four technical objectives to expand its product offering and successfully bring the Phase I technology to market. The award is designated for total small...
<p>This is a $229,893.00 Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Cairn Biosciences Inc., a woman-owned small business. The contract is for the development of a "MULTIPLEXED HIGH CONTENT ASSAY FOR TOXICITY MECHANISMS AND PHENOTYPES IN LIVE IPSC-DERIVED CARDIAC CELLS." The contract is a definitive, firm-fixed price contract with a completion date of May 14, 2017.</p>
The Department of Health and Human Services National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) awarded a Firm Fixed Price definitive contract to Akula, Nirmala, a woman-owned small business. The contract, valued at $462,631.70, is for bioinformatics services to support the operational objectives of the NIMH Intramural Research Program (NIMH IRP) through the analysis of data generated within the Human Genetics Branch. The contract was set aside for a woman-owned small...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a Small Business Innovation Research (SBIR) Program Phase I contract to B & W TEK Inc., a for-profit manufacturing organization, to develop new commercially viable devices, tools, technologies or integrated systems for drug detection and deactivation to deter opioid theft in hospitals. The definitive, firm fixed-price contract has a potential value of $224,656.02 and a...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $212,257.09 firm fixed-price purchase order contract to Alliant Enterprises, LLC, a Service-Disabled Veteran-Owned Small Business, to provide a bioluminescence imaging system on a brand-name or equal basis to the Olympus LV200 system. The contract was set aside for small businesses and has a completion date of December 15, 2024. The system is being acquired to support the Stem...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $150,000.00 firm fixed-price purchase order contract to the New York Stem Cell Foundation Inc., a non-profit organization that conducts stem cell research. The contract is for services related to stem cell research, including generating induced pluripotent stem cell lines, differentiating stem cells into insulin-producing beta cells, and expanding and validating neural...
This is a $300,000.00 Firm Fixed Price Definitive Contract awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Vala Sciences Inc. to conduct Small Business Innovation Research (SBIR) Phase I research and development on the "Development of Novel In-Vitro and In-Vivo Models to Support NeuroHIV Research." The contract was set aside for small businesses and has an ultimate completion date of September 26, 2025. Vala Sciences...
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $163,000 cost-plus-fixed-fee delivery order contract to Lovelace Biomedical Research Institute. The contract is for the assessment of potential treatments for drug-induced respiratory depression and overdose toxicity under Task Order 75N95022F00002 of an unspecified multiple award contract vehicle. Lovelace will conduct the assessment from September 2022 through September 2024...